Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Matthew Sean Petitt , DO

Dermatology - Dermatopathology • Pasadena, TX

Active NPI 1912101593 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

4419 Crenshaw Rd
Pasadena, TX 775043628

Call 2819915944 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

4419 Crenshaw Rd

Pasadena, TX 775043628

Telephone 2819915944
Organization at the Same NPPES Address or Phone
Southeast Dermatology, P.a. Facility NPI 1811932205

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Southeast Dermatology, P.A.. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Graduation Year

2002

Medicare patients

2,511 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $663,857 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $508,626 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,971 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$1,001,565 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $4,272.98 across 220 records.

By nature of payment

  • Food and Beverage: $4,272.98 across 220 records.

Reporting-company totals (3 largest of 24)

  • ABBVIE INC.: $629.86 across 40 records.
  • Sanofi and Genzyme US Companies: $467.01 across 13 records.
  • Janssen Pharmaceuticals, Inc: $415.64 across 18 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

24 years (graduated 2002)

CMS Doctors and Clinicians data list 2002 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2007

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Petitt has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Petitt as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Pasadena and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 75% of clinicians listed under Dermatology - Dermatopathology in Texas (2024, 26 clinicians with data). Median for this group: 4,449. Middle half: 1,929 to 9,278.

Too few clinicians listed under Dermatology - Dermatopathology in Pasadena have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 80% of clinicians listed under Dermatology - Dermatopathology in Texas (2024, 26 clinicians with data). Median for this group: $233,519. Middle half: $103,973 to $469,823.

Too few clinicians listed under Dermatology - Dermatopathology in Pasadena have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 80% of clinicians listed under Dermatology - Dermatopathology in Texas (2024, 26 clinicians with data). Median for this group: $176,252. Middle half: $68,760 to $352,069.

Too few clinicians listed under Dermatology - Dermatopathology in Pasadena have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 90% of clinicians listed under Dermatology - Dermatopathology in Texas (2024, 27 clinicians with data). Median for this group: 389. Middle half: 50 to 645.

Too few clinicians listed under Dermatology - Dermatopathology in Pasadena have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Dermatology - Dermatopathology in Texas (2024, 27 clinicians with data). Median for this group: $120,869. Middle half: $5,393 to $258,264.

Too few clinicians listed under Dermatology - Dermatopathology in Pasadena have Medicare Part D data for 2024 to compare.

1 active clinicians are listed under Dermatology - Dermatopathology with a practice address in Pasadena, TX (42 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 220 records totaling $4,272.98.

Manufacturer Payment Nature Product Type Amount ($)
Pfizer Inc.
Food and Beverage
In-kind items and services
CIBINQO General $106.21
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $47.38
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $44.88
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
ILUMYA General $44.53
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $41.33
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $40.44
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $37.26
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
ILUMYA General $36.75
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $35.80
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $35.25
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $35.03
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $34.70
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $34.36
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $33.23
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $32.92
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $32.32
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $32.09
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $31.97
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $31.93
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $31.58
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $31.47
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $31.41
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $31.33
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $31.33
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $30.52

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
88305 Pathology examination of tissue using a microscope, intermediate complexity
4,233 2,205 $169.98 $74.48
17003 Destruction of precancer skin growth, 2-14 growths
1,544 250 $25.00 $6.89
88341 Special stained specimen slides to examine tissue, each additional procedure
884 254 $47.00 $28.36
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
493 338 $152.00 $95.63
17000 Destruction of precancer skin growth, 1 growth
476 308 $111.00 $48.05
11102 Biopsy of related skin growth, first growth
379 300 $175.00 $94.29
88342 Special stained specimen slides to examine tissue, initial procedure
278 254 $58.00 $35.34
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
263 171 $215.00 $135.10
88304 Pathology examination of tissue using a microscope, moderately low complexity
242 208 $100.00 $44.90
11103 Biopsy of related skin growth, each additional growth
206 122 $89.00 $52.65
17110 Destruction of skin growth, 1-14 growths
145 110 $191.00 $114.05
88312 Special stained specimen slides to identify organisms including interpretation and report
127 85 $186.00 $115.61
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
89 89 $186.00 $118.52
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
50 47 $731.00 $428.53
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
46 43 $806.00 $496.10
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
44 43 $416.00 $129.61
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
42 30 $300.00 $143.89
17004 Destruction of precancer skin growth, 15 or more growths
35 25 $278.00 $175.80
88313 Special stained specimen slides to examine tissue including interpretation and report
32 26 $134.00 $86.51
13101 Complicated repair of wound of trunk, 2.6-7.5 cm
25 24 $684.00 $393.57
11642 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
23 21 $455.00 $142.29
69100 Biopsy of ear
21 20 $167.00 $72.02
11104 Punch biopsy, first skin growth
19 17 $219.00 $128.38
11622 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
19 18 $429.00 $129.82
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
17 15 $473.00 $147.85

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Mupirocin Mupirocin 275 5,024 $1,873.30 212
Doxycycline Hyclate Doxycycline Hyclate 215 5,387 $3,264.73 126
Clobetasol Propionate Clobetasol Propionate 156 4,540 $5,195.42 77
Triamcinolone Acetonide Triamcinolone Acetonide 106 3,621 $940.07 64
Ketoconazole Ketoconazole 98 2,802 $1,276.50 52
Prednisone Prednisone 59 1,433 $268.05 27
Desoximetasone Desoximetasone 57 1,705 $3,327.54 39
Desonide Desonide 53 1,481 $2,129.32 35
Minoxidil Minoxidil 49 3,870 $466.02 15
Dupixent Pen Dupilumab 49 1,652 $216,391.07 —
Azithromycin Azithromycin 46 320 $190.61 42
Tretinoin Tretinoin 46 1,455 $3,005.31 24
Econazole Nitrate Econazole Nitrate 36 1,177 $1,334.35 21
Hydrocortisone Hydrocortisone 34 907 $205.13 23
Clindamycin Phosphate Clindamycin Phosphate 32 855 $813.14 16
Cephalexin Cephalexin 30 80 $76.40 25
Fluorouracil Fluorouracil 27 797 $1,835.87 26
Metronidazole Metronidazole 25 812 $849.34 18
Opzelura Ruxolitinib Phosphate 25 750 $48,815.60 —
Fluocinonide Fluocinonide 24 675 $574.75 12
Taltz Autoinjector Ixekizumab 24 672 $163,758.53 —
Dupixent Syringe Dupilumab 23 644 $85,965.72 —
Valacyclovir Valacyclovir Hcl 22 453 $485.64 11
Terbinafine Hcl Terbinafine Hcl 20 577 $117.45 11
Hydroxyzine Hcl Hydroxyzine Hcl 17 549 $102.85 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2022-06-13
Dermatology - Dermatopathology Primary Specialty

NUCC Taxonomy Code: 207ND0900X

License # reported to NPPES TX M2750

A dermatopathologist has the expertise to diagnose and monitor diseases of the skin including infectious, immunologic, degenerative and neoplastic diseases. This entails the examination and interpretation of specially prepared tissue sections, cellular scrapings and smears of skin lesions by means of routine and special (electron and fluorescent) microscopes.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Other Identifier Myutmb 3853003243-Commercial Number
3853003243

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20100219000633

Enrollment State Jurisdiction

TX

PECOS Control ID

9931243508

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Southeast Dermatology, P.a.

4419 Crenshaw Rd, Pasadena, TX 775043628

Phone: 2819915944

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

9 listed
NPI 1194709626

Doctor of Medicine (M.D.)

NPI 1346277381

Doctor of Medicine (M.D.)

NPI 1851392039

Doctor of Medicine (M.D.)

NPI 1366607194

Doctor of Medicine (M.D.)

NPI 1316905029

Doctor of Medicine (M.D.)

NPI 1922393131

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated June 14, 2007.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1912101593
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: June 14, 2007
Last Update: June 13, 2022
Sole Proprietor: No

Mailing Address

4419 Crenshaw Rd

Pasadena, TX 775043628

Phone: 2819915944

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.